<DOC>
	<DOCNO>NCT03074994</DOCNO>
	<brief_summary>Post-operative bleeding total knee arthroplasty ( TKA ) result hypovolemic shock unnecessity allogenic blood transfusion . Intravenous topical tranexamic acid ( TXA ) well establish reduce blood loss postoperatively . However , lack data peri-articular TXA injection TKA . Therefore , investigator conduct three-arm prospective , randomize , control trial compare effectiveness bleed reduction peri-articular TXA injection , intraarticular TXA injection control group .</brief_summary>
	<brief_title>The Comparative Efficacy Peri-articular Intraarticular Tranexamic Acid Total Knee Arthroplasty</brief_title>
	<detailed_description>Patients schedule unilateral primary TKA ; 108 patient randomly assign receive peri-articular TXA , intraarticular TXA control group . 36 patient receive either : ( I ) 15 mg/kg peri-articular TXA combine multimodal local anesthetic infiltration ( bupivacaine , morphine , ketorolac epinephrine ) anterior soft tissue , medial gutter area , lateral gutter area prior capsular closure tourniquet deflation ( group 1 ) . ( II ) 2 g intraarticular TXA complete capsular closure tourniquet deflation ( group 2 ) . ( III ) Do n't receive route TXA control group ( group 3 ) . Hemoglobin ( Hb ) concentration measure 24 48 hour , number blood transfusion knee circumference measurement record . Serum TXA record 2 24 hour operation . The reviewer blind treatment group .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Adult patient osteoarthritis need TKA Inflammatory arthritis Posttraumatic arthritis A history current venous thromboembolic disease Any underlying disease haemostasis , cirrhosis , chronic renal failure , patient anticoagulant strong antiplatelet drug ( e.g . warfarin , clopidogrel ) Preoperative hemoglobin &lt; 10 g/dL platelet count &lt; 140,000 /uL3 Allergy TXA</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Tranexamic acid</keyword>
	<keyword>Peri-articular injection</keyword>
	<keyword>Intraarticular injection</keyword>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Blood loss</keyword>
</DOC>